Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

The Lancet Respiratory Medicine · Published 2025-01-01 · Available online 24 Feb 2020 · Journal article · DOI 10.1016/s2213-2600(20)30079-5

Authors being retrieved — see the publisher record. https://doi.org/10.1016/s2213-2600(20)30079-5

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Characteristics, Associated Factors, and Outcomes of Cardiac Arrest in Critically Ill COVID-19 Patients in the Intensive Care Unit: A Single-Center Retrospective Study · COVID · 2026 · Cites or is cited by this article
• Investigation of PDCD1 Gene Polymorphisms and Haplotypes in COVID‐19 Severity and Outcome in a Brazilian Population · Journal of Medical Virology · 2026 · Cites or is cited by this article
• Critically ill COVID-19 phenotypes identified by unsupervised clustering: A multicenter retrospective ICU study · Heart and Lung · 2026 · Cites or is cited by this article
• Toxic skies of war · The Lancet Respiratory Medicine · 2026 · Same journal
• Cryobiopsy versus conventional bronchoscopic sampling for peripheral pulmonary lesions (Cryo-RCT): an open-label, parallel-group, randomised trial · The Lancet Respiratory Medicine · 2026 · Same journal
• Challenging dogmata of oxygen therapy in acute childhood illness · The Lancet Respiratory Medicine · 2026 · Same journal
• The PERC-Peds rule: a promising step towards structured pulmonary embolism risk assessment in children · The Lancet Respiratory Medicine · 2026 · Same journal
• Sphaerosymphony: turning air quality data into music · The Lancet Respiratory Medicine · 2026 · Same journal
• Effects of inflammatory phenotypes in acute respiratory distress syndrome on mortality and partitioning of lung and chest wall mechanics in patients in the USA and Canada: a retrospective cohort study · The Lancet Respiratory Medicine · 2026 · Same journal
• Global economic burden attributable to asthma, 2025–50: a global modelling analysis of 154 countries and territories · The Lancet Respiratory Medicine · 2026 · Same journal